Computer models determine drug candidate’s ability to bind to proteins
Research by University of Arkansas scientists into the binding affinity of potential drugs could help reduce the cost and time associated with developing new drugs.
List view / Grid view
Research by University of Arkansas scientists into the binding affinity of potential drugs could help reduce the cost and time associated with developing new drugs.
Discover how Catalent can help you achieve efficiencies and develop a robust, reproducible manufacturing plan for late-stage and commercial launch.
Combining AI with cutting-edge flow cytometry and massive sequencing technologies, researchers describe CAR T cell characteristics that determine their therapeutic capacity for the first time.
Finnish researchers have developed AI based neural network to detect an early knee osteoarthritis from x-ray images, that can save the patient from unnecessary examinations, treatments and even knee joint replacement surgery.
Read about the current state of the industry, challenges associated with potency assays and measuring product potency throughout the manufacturing process.
US researchers, using new machine learning techniques have developed a virtual molecular library of “words” that encode commands to kill cancer cells.
Understand how quality control assays are being implemented in monitoring the development of CAR-T cells using high-throughput technologies in this article.
Cytokine multiplex assays allow researchers to measure multiple cytokines, chemokines and growth factors from one small sample.
A new Drug Target Review issue is now ready to download! This issue features articles which explore how artificial intelligence can enhance screening and ways to find new hits through simultaneous orthogonal screens. Also included are articles on CRISPR, immuno-oncology and RSV vaccines.
The pipetting robot, flowbot® ONE, is available with a HEPA filter to make clean-up processes easy and effective, enabling you to keep your samples safe.
Swedish researchers have designed synthetic DNA that controls a cells’ protein production using AI.
Get useful insights into whether you should automate your lab and what to consider if you do – all to help you choose the right solution for your specific lab and keep your employees happy.
Researchers have streamlined the traditionally slow process of enzyme engineering. This work might help researchers tailor the suitability of enzymes for custom purposes.
Researchers have used AI to design microneedle patches that restore hair in balding mice.
1 November 2022 | By Standard BioTools
Watch our on-demand webinar to hear about advances toward precision medicine through the use of cutting-edge methods and analysing critical patient immune data in response to therapies and disease progression.